Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients

• Hauptverfasser: Eva Thijssen (VerfasserIn), Bert Tuk (VerfasserIn), Michel Cakici (VerfasserIn), Veerle vanVelze (VerfasserIn), Erica Klaassen (VerfasserIn), Frans Merkus (VerfasserIn), Teus vanLaar (VerfasserIn), Philip Kremer (VerfasserIn), Geert Jan Groeneveld (VerfasserIn)
• Format: Buch
• Veröffentlicht: Wiley, 2024-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Apomorphine, used to treat OFF episodes in patients with Parkinson's disease (PD), is typically administered via subcutaneous injections. Administration of an oromucosal solution could offer a non‐invasive and user‐friendly alternative. This two‐part clinical study evaluated the safety...